Root Admin Guide Posted September 14, 2017 Root Admin Report Share Posted September 14, 2017 An article was released by DovePress regarding, "a responder definition for the treatment of papulopustular rosacea." So what is a 'responder'? According the authors of this paper, "patients with treatment success, i.e., improvement in the Investigator Global Assessment (IGA) to “clear” or “minimal” were called “responders,” and those with treatment failure, i.e., staying in the range of IGA “mild” to “severe” were called “nonresponders”." The paper further stated that, "The goal of our study was to empirically generate a responder definition based on the number of facial rosacea lesions." The authors concluded, "The calculated cutoff point of 5.69 lesions allows discrimination of responders (5 or less remaining lesions) and nonresponders (6 or more remaining lesions) of therapeutic interventions in rosacea. As this is the first publication providing a responder definition based on the number of lesions, we suggest utilizing both end points – IGA and number of lesions – in clinical research programs for the near future." Clinical, Cosmetic and Investigational Dermatology, September 8, 2017, DovepressAn empirically generated responder definition for rosacea treatment • Full Text Staedtler G, Shakery K, Endrikat J, Nkulikiyinka R, Gerlinger C Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now